Results about: antibodies

The immune system of the alpaca reveals a potential treatment for cancer

A study done at IRB Barcelona and the Vrije Universiteit Brussel identifies camelid nanobodies able to block EGF, a protein that is abundant in tumour cells and that helps them to proliferate.

IRB Barcelona and Merus form a research collaboration to develop antibodies targeting the tumor microenvironment

The research collaboration will combine Merus’ Biclonics technology platform and unique cell and animal models at the Colorectal Cancer Laboratory led by Eduard Batlle to investigate the stroma.